[1]
G. Traina, “Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma”., Acta Biomed, vol. 92, no. 1, p. e2021037, Feb. 2021, doi: 10.23750/abm.v92i1.9096.